Canakinumab for Atherosclerotic Disease

Kasper F Hjuler, Alexander Egeberg

Dermatology and Allergy

Original language	English
Journal	The New England journal of medicine
Volume	378
Issue number	2
Pages (from-to)	197
ISSN	0028-4793
DOIs	https://doi.org/10.1056/NEJMc1714635
Publication status	Published - 11 Jan 2018

Keywords

Antibodies, Monoclonal
Atherosclerosis
Humans

Access to Document

10.1056/NEJMc1714635

Cite this

@article{6fab6492cb87428ab99eeecbe655fe58,

title = "Canakinumab for Atherosclerotic Disease",

keywords = "Antibodies, Monoclonal, Atherosclerosis, Humans",

author = "Hjuler, {Kasper F} and Alexander Egeberg",

year = "2018",

month = jan,

day = "11",

doi = "10.1056/NEJMc1714635",

language = "English",

volume = "378",

pages = "197",

journal = "The New England journal of medicine",

issn = "0028-4793",

publisher = "Massachusetts Medical Society",

number = "2",

}

TY - JOUR

T1 - Canakinumab for Atherosclerotic Disease

AU - Hjuler, Kasper F

AU - Egeberg, Alexander

PY - 2018/1/11

Y1 - 2018/1/11

KW - Antibodies, Monoclonal

KW - Atherosclerosis

KW - Humans

U2 - 10.1056/NEJMc1714635

DO - 10.1056/NEJMc1714635

M3 - Journal article

C2 - 29322755

SN - 0028-4793

VL - 378

SP - 197

JO - The New England journal of medicine

JF - The New England journal of medicine

IS - 2

ER -